Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cardiovascular MRI Aids Diastolic Heart Failure Diagnosis

By HospiMedica International staff writers
Posted on 20 Nov 2017
A new study will investigate whether diastolic heart failure (DHF) can be better diagnosed with the help of cardiovascular magnetic resonance imaging (CMRI).

Researchers at the German Centre for Cardiovascular Research (DZHK; Berlin, Germany) and University Hospital Frankfurt (Germany) are launching a multicenter study to establish CMRI as the standard method for diagnosing DHF, also known as heart failure with preserved ejection fraction (HFpEF). More...
The study will compare CMR diagnostic data efficacy with that of the present gold standard, invasive hemodynamics, in which patients are examined using a cardiac catheter.

In order to obtain a more comprehensive picture of the diagnostic validity of CMR, the researchers will also compare CMR measurements to the results of ultrasound examinations and analyses of myocardial tissue samples. The data will also aid the researchers investigate whether CMR can help clarify why DHF disease arises, since unlike an ultrasound, CMR not only measures blood flow and ventricular filling, but can also identify an inflamed myocardium, pathological proliferation of the connective tissue, and change to small blood vessels.

“Only once the causes are clear can patients receive targeted medicinal therapy, because the treatment of myocardial inflammation differs entirely to that of a circulatory disorder. Therapeutic studies are only possible once we can distinguish between the various patient subgroups,” said lead researcher Professor Eike Nagel, MD, of University Hospital Frankfurt. “It is the first multicenter study on the diagnosis of HFpEF worldwide. Beside Frankfurt am Main, the DZHK sites in Berlin, Heidelberg, Göttingen, and Bad Nauheim are also participating. If the results are positive, the study would lead to a modification of the guidelines for diagnosing HFpEF.”

HFpEF is a complex disease, encompassing a diverse cohort of patients and marked by the presence of multiple etiological mechanisms. Diastolic dysfunction, in which the heart contracts properly, but cannot expand enough so that blood can fill the chamber, is considered a crucial component of the disease, which affects approximately 50% of patients with chronic heart failure (HF).

CMR is a medical imaging technology for the non-invasive assessment of the function and structure of the cardiovascular system that is based on the same basic principles as MRI, with optimizations that use rapid imaging sequences, requiring CMR images be acquired in steps. Patients breathe in and then hold their breath for each image, then recover before repeating the process for the next one.

Related Links:
German Centre for Cardiovascular Research
University Hospital Frankfurt


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Rapid Sepsis Test
SeptiCyte RAPID
New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.